AU6100680A - Prevention of metastasis - Google Patents

Prevention of metastasis

Info

Publication number
AU6100680A
AU6100680A AU61006/80A AU6100680A AU6100680A AU 6100680 A AU6100680 A AU 6100680A AU 61006/80 A AU61006/80 A AU 61006/80A AU 6100680 A AU6100680 A AU 6100680A AU 6100680 A AU6100680 A AU 6100680A
Authority
AU
Australia
Prior art keywords
metastasis
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU61006/80A
Other versions
AU539070B2 (en
Inventor
Walter Haarmann
Erich Muller
Berthold Narr
Josef Nickl
Josef Roch
Johannes-Maximilian Weisenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of AU6100680A publication Critical patent/AU6100680A/en
Application granted granted Critical
Publication of AU539070B2 publication Critical patent/AU539070B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AU61006/80A 1979-08-04 1980-08-01 Prevention of metastasis Ceased AU539070B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE29317417 1979-08-04
DE19792931741 DE2931741A1 (en) 1979-08-04 1979-08-04 anti-metastasis medicaments - comprising derivs. of carbostyril and analogues

Publications (2)

Publication Number Publication Date
AU6100680A true AU6100680A (en) 1981-02-12
AU539070B2 AU539070B2 (en) 1984-09-13

Family

ID=6077677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61006/80A Ceased AU539070B2 (en) 1979-08-04 1980-08-01 Prevention of metastasis

Country Status (7)

Country Link
JP (1) JPS5636452A (en)
AU (1) AU539070B2 (en)
BE (1) BE884628A (en)
DE (1) DE2931741A1 (en)
IT (1) IT1212438B (en)
NZ (1) NZ194531A (en)
ZA (1) ZA804680B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464833A (en) * 1992-08-19 1995-11-07 Otsuka Pharmaceutical Co., Ltd. Apoptosis regulating composition
US5635514A (en) * 1994-10-25 1997-06-03 G. D. Searle & Company Heteroaralkyl and heteroarylthioalkyl thiophenolic compounds as 5-lipoxgenase inhibitors

Also Published As

Publication number Publication date
NZ194531A (en) 1984-08-24
AU539070B2 (en) 1984-09-13
DE2931741A1 (en) 1981-02-26
IT1212438B (en) 1989-11-22
ZA804680B (en) 1982-04-28
IT8023121A0 (en) 1980-06-30
BE884628A (en) 1981-02-04
JPS5636452A (en) 1981-04-09

Similar Documents

Publication Publication Date Title
AU538740B2 (en) Amides of acyl-carnitines
AU534647B2 (en) Monacolin k
ZA807631B (en) Oligomrtization of oleffins
AU527075B2 (en) Electrolyas of hc1
AU538652B2 (en) Manufacture of thermplastics pipe
AU524975B2 (en) Rate of change detection
AU533653B2 (en) Novel mercaptoorganosiloxanes
AU548488B2 (en) Manufacture of alkylaminoalkanol
AU534333B2 (en) Purification of glycohaemoglobins
AU536516B2 (en) Novel compounds of the muramyl-peptide type
AU536642B2 (en) Seal
AU532293B2 (en) Ergol-8-ene and ergolin compounds
AU6013780A (en) Compositions of benzothiazolones
AU524017B2 (en) Hydroliquefaction of coal
AU524016B2 (en) Hydroliquefaction of coal
AU539070B2 (en) Prevention of metastasis
AU536572B2 (en) Novel mercaptoorganopolysiloxanes
AU535970B2 (en) Perfluoroamides of n-phosphonomethyl-glycinonitrile
AU527694B2 (en) Manufacture of fusecord
AU529586B2 (en) Synthesis of 2-isopropylamino-pyrimidine
JPS55145619A (en) Separation of ppxylene
AU532084B2 (en) Preparation of flunisolide
AU531020B2 (en) Prevention of explosions
AU5851180A (en) Reduction of ores
AU7455381A (en) Reduction of ferrotitaniferous materials